• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Results of a national UK physician reported survey of COVID-19 infection in patients with a myeloproliferative neoplasm.

作者信息

Salisbury Richard A, Curto-Garcia Natalia, O'Sullivan Jennifer, Chen Frederick, Polzella Paolo, Godfrey Anna L, Russell James, Knapper Steven, Willan John, Frewin Rebecca, Joshi Shivani, Arami Siamak, Burns Sarah, Teh Chun Huat, Wadelin Frances, Dhanapal Jaymathi, Neelakantan Pratap, Milojkovic Dragana, Psaila Beth, Szydlo Richard, Francis Sebastian, Cargo Catherine, Jain Manish, McGregor Andrew, Wallis Louise, Duncombe Andrew, Hussein Hayder, Dyer Peter, Munro Laura, Bond Lee, McMullin Mary Frances, Somervaille Tim C P, Garg Mamta, Sekhar Mallika, Harrison Claire, Mead Adam J, Innes Andrew J

机构信息

NIHR Biomedical Research Centre and MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.

Department of Haematology, Guys and St Thomas' NHS Foundation Trust, London, UK.

出版信息

Leukemia. 2021 Aug;35(8):2424-2430. doi: 10.1038/s41375-021-01143-2. Epub 2021 Feb 12.

DOI:10.1038/s41375-021-01143-2
PMID:33580204
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7880652/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9af8/8324473/ea56391fcdfa/41375_2021_1143_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9af8/8324473/ea56391fcdfa/41375_2021_1143_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9af8/8324473/ea56391fcdfa/41375_2021_1143_Fig1_HTML.jpg

相似文献

1
Results of a national UK physician reported survey of COVID-19 infection in patients with a myeloproliferative neoplasm.英国一项由医生报告的关于骨髓增殖性肿瘤患者新冠病毒感染情况的全国性调查结果。
Leukemia. 2021 Aug;35(8):2424-2430. doi: 10.1038/s41375-021-01143-2. Epub 2021 Feb 12.
2
Long-term follow-up of recovered MPN patients with COVID-19.新冠病毒感染康复的骨髓增殖性肿瘤患者的长期随访
Blood Cancer J. 2021 Jun 16;11(6):115. doi: 10.1038/s41408-021-00509-0.
3
Challenges of patients with myeloproliferative neoplasms (MPN) in times of COVID: First results from a patient survey by the German Study Group for MPN.骨髓增殖性肿瘤（MPN）患者在新冠疫情期间面临的挑战：德国MPN研究小组患者调查的初步结果
Leuk Res. 2021 Nov;110:106646. doi: 10.1016/j.leukres.2021.106646. Epub 2021 Jun 16.
4
Second versus first wave of COVID-19 in patients with MPN.骨髓增殖性肿瘤患者中新冠病毒病的第二波与第一波疫情情况对比
Leukemia. 2022 Mar;36(3):897-900. doi: 10.1038/s41375-022-01507-2. Epub 2022 Jan 21.
5
Outcome of COVID-19 in patients with chronic myeloid leukemia: A single centre UK experience.慢性髓性白血病患者的COVID-19结局：英国单中心经验
J Med Virol. 2022 Apr;94(4):1274-1276. doi: 10.1002/jmv.27527. Epub 2021 Dec 21.
6
Addressing the impact of SARS-CoV-2 infection in persons with congenital bleeding disorders: The Italian MECCOVID-19 study.评估严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染对先天性出血性疾病患者的影响：意大利MECCOVID-19研究。
Haemophilia. 2021 Jul;27(4):e575-e578. doi: 10.1111/hae.14331. Epub 2021 May 13.
7
Travel from the United Kingdom to the United States by a Symptomatic Patient Infected with the SARS-CoV-2 B.1.1.7 Variant - Texas, January 2021.从英国到美国的旅行：由感染 SARS-CoV-2 B.1.1.7 变异株的有症状患者引起 - 德克萨斯州，2021 年 1 月。
MMWR Morb Mortal Wkly Rep. 2021 Mar 12;70(10):348-349. doi: 10.15585/mmwr.mm7010e2.
8
Philadelphia-Negative Myeloproliferative Neoplasms Around the COVID-19 Pandemic.新冠疫情期间的费城染色体阴性骨髓增殖性肿瘤
Curr Hematol Malig Rep. 2021 Oct;16(5):455-463. doi: 10.1007/s11899-021-00647-z. Epub 2021 Sep 29.
9
Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism.无骨髓增殖性肿瘤的新冠病毒感染患者出现血小板增多症与较好的预后相关，但静脉血栓栓塞发生率较高。
Blood Cancer J. 2021 Nov 29;11(11):189. doi: 10.1038/s41408-021-00585-2.
10
COVID-19 infection in patients with severe aplastic anaemia.重型再生障碍性贫血患者的新型冠状病毒肺炎感染
Br J Haematol. 2021 Jun;193(5):902-905. doi: 10.1111/bjh.17415. Epub 2021 Apr 29.

引用本文的文献

1
Non-Myelofibrosis Chronic Myeloproliferative Neoplasm Patients Show Better Seroconversion Rates after SARS-CoV-2 Vaccination Compared to Other Hematologic Diseases: A Multicentric Prospective Study of KroHem.与其他血液疾病相比，非骨髓纤维化慢性骨髓增殖性肿瘤患者在接种新型冠状病毒疫苗后血清转化率更高：一项KroHem的多中心前瞻性研究。
Biomedicines. 2022 Nov 11;10(11):2892. doi: 10.3390/biomedicines10112892.
2
Predictors of clinical evolution of SARS-CoV-2 infection in hematological patients: A systematic review and meta-analysis.预测 SARS-CoV-2 感染在血液病患者中的临床演变的因素：系统评价和荟萃分析。
Hematol Oncol. 2023 Feb;41(1):16-25. doi: 10.1002/hon.3084. Epub 2022 Oct 20.
3

本文引用的文献

1
A retrospective real-world study of the current treatment pathways for myelofibrosis in the United Kingdom: the REALISM UK study.英国骨髓纤维化当前治疗途径的回顾性真实世界研究：英国REALISM研究
Ther Adv Hematol. 2022 Mar 28;13:20406207221084487. doi: 10.1177/20406207221084487. eCollection 2022.
2
When hematologic malignancies meet COVID-19 in the United States: Infections, death and disparities.当血液系统恶性肿瘤在美国遭遇 COVID-19：感染、死亡和差异。
Blood Rev. 2021 May;47:100775. doi: 10.1016/j.blre.2020.100775. Epub 2020 Nov 9.
3
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study.
COVID-19 outcomes in patients with cancer: Findings from the University of California health system database.
癌症患者的 COVID-19 结局：来自加利福尼亚大学健康系统数据库的研究结果。
Cancer Med. 2022 Jun;11(11):2204-2215. doi: 10.1002/cam4.4604. Epub 2022 Mar 9.
4
Philadelphia-Negative Chronic Myeloproliferative Neoplasms during the COVID-19 Pandemic: Challenges and Future Scenarios.新冠疫情期间的费城染色体阴性慢性骨髓增殖性肿瘤：挑战与未来展望
Cancers (Basel). 2021 Sep 23;13(19):4750. doi: 10.3390/cancers13194750.
5
The immune landscape in BCR-ABL negative myeloproliferative neoplasms: inflammation, infections and opportunities for immunotherapy.BCR-ABL 阴性骨髓增殖性肿瘤中的免疫景观：炎症、感染和免疫治疗机会。
Br J Haematol. 2022 Mar;196(5):1149-1158. doi: 10.1111/bjh.17850. Epub 2021 Oct 7.
6
Large Scale Internet-based Survey of Patients With a Myeloproliferative Neoplasm: Opinions and Experiences Regarding SARS-CoV-2 (COVID-19) Vaccination Strategies in 2021.基于互联网的骨髓增殖性肿瘤患者大规模调查：2021年关于严重急性呼吸综合征冠状病毒2（SARS-CoV-2，即新冠病毒）疫苗接种策略的意见和经验
Hemasphere. 2021 Jun 23;5(7):e609. doi: 10.1097/HS9.0000000000000609. eCollection 2021 Jul.
7
Impaired antibody response to COVID-19 vaccination in patients with chronic myeloid neoplasms.慢性髓系肿瘤患者对新冠病毒疫苗接种的抗体反应受损。
Br J Haematol. 2021 Sep;194(6):1010-1015. doi: 10.1111/bjh.17644. Epub 2021 Jun 24.
意大利血液系统恶性肿瘤患者中与COVID-19严重程度相关的临床特征和危险因素：一项回顾性、多中心队列研究。
Lancet Haematol. 2020 Oct;7(10):e737-e745. doi: 10.1016/S2352-3026(20)30251-9. Epub 2020 Aug 13.
4
Outcomes of COVID-19 in patients with CLL: a multicenter international experience.慢性淋巴细胞白血病患者感染新型冠状病毒肺炎的结局：一项多中心国际经验
Blood. 2020 Sep 3;136(10):1134-1143. doi: 10.1182/blood.2020006965.
5
Factors associated with COVID-19-related death using OpenSAFELY.使用 OpenSAFELY 分析与 COVID-19 相关死亡的因素。
Nature. 2020 Aug;584(7821):430-436. doi: 10.1038/s41586-020-2521-4. Epub 2020 Jul 8.
6
Risk of infections in patients with myeloproliferative neoplasms-a population-based cohort study of 8363 patients.骨髓增殖性肿瘤患者的感染风险：一项基于人群的 8363 例患者的队列研究。
Leukemia. 2021 Feb;35(2):476-484. doi: 10.1038/s41375-020-0909-7. Epub 2020 Jun 16.
7
Holding CoVID in check through JAK? The MPN-approved compound ruxolitinib as a potential strategy to treat SARS-CoV-2 induced systemic hyperinflammation.通过JAK抑制新冠病毒？骨髓增殖性肿瘤（MPN）获批药物鲁索替尼作为治疗SARS-CoV-2诱导的全身炎症反应的潜在策略。
Leukemia. 2020 Jul;34(7):1723-1725. doi: 10.1038/s41375-020-0898-6. Epub 2020 Jun 11.
8
COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection.COVID-19 和凝血：SARS-CoV-2 感染的出血和血栓形成表现。
Blood. 2020 Jul 23;136(4):489-500. doi: 10.1182/blood.2020006520.
9
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.使用 ISARIC WHO 临床特征协议住院的 20133 例英国新冠患者的特征：前瞻性观察队列研究。
BMJ. 2020 May 22;369:m1985. doi: 10.1136/bmj.m1985.
10
Risk factors for vascular complications and treatment patterns at diagnosis of 2389 PV and ET patients: Real-world data from the Swedish MPN Registry.2389例真性红细胞增多症和原发性血小板增多症患者诊断时血管并发症的危险因素及治疗模式：来自瑞典骨髓增殖性肿瘤登记处的真实世界数据。
Eur J Haematol. 2017 Jun;98(6):577-583. doi: 10.1111/ejh.12873. Epub 2017 Apr 3.